APA (7th ed.) Citation

Kajiwara, A., Saruwatari, J., Kita, A., Oniki, K., Yamamura, M., Murase, M., . . . Nakagawa, K. (2014). Younger Females Are at Greater Risk of Vasodilation-Related Adverse Symptoms Caused by Dihydropyridine Calcium Channel Blockers: Results of a Study of 11,918 Japanese Patients. Clinical Drug Investigation, 34(6), 431. https://doi.org/10.1007/s40261-014-0191-4

Chicago Style (17th ed.) Citation

Kajiwara, Ayami, et al. "Younger Females Are at Greater Risk of Vasodilation-Related Adverse Symptoms Caused by Dihydropyridine Calcium Channel Blockers: Results of a Study of 11,918 Japanese Patients." Clinical Drug Investigation 34, no. 6 (2014): 431. https://doi.org/10.1007/s40261-014-0191-4.

MLA (9th ed.) Citation

Kajiwara, Ayami, et al. "Younger Females Are at Greater Risk of Vasodilation-Related Adverse Symptoms Caused by Dihydropyridine Calcium Channel Blockers: Results of a Study of 11,918 Japanese Patients." Clinical Drug Investigation, vol. 34, no. 6, 2014, p. 431, https://doi.org/10.1007/s40261-014-0191-4.